Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Construction and validation of an immune prognostic risk model in oral squamous cell carcinoma]. | Shanghai Kou Qiang Yi Xue | 2024 | 39478389 | PubTator, text mining | PubMed |
| Endothelin-1 potentiated constriction in preeclampsia placental veins: Role of ETAR/ETBR/CaV1.2/CALD1. | Placenta | 2024 | 39476475 | PubTator, text mining | PubMed |
| EDNRA affects susceptibility to large artery atherosclerosis stroke through potential inflammatory pathway. | Sci Rep | 2024 | 39448657 | PubTator, text mining | PubMed |
| Cisplatin-resistance and aggressiveness are enhanced by a highly stable endothelin-converting enzyme-1c in lung cancer cells. | Biol Res | 2024 | 39443981 | PubTator, text mining | PubMed |
| [Postoperative Management of Aneurysmal Subarachnoid Hemorrhage]. | No Shinkei Geka | 2024 | 39285539 | PubTator, text mining | PubMed |
| Expression profile of messenger and micro RNAs related to the histaminergic system in patients with five subtypes of breast cancer. | Front Oncol | 2024 | 39267843 | PubTator, text mining | PubMed |
| Genetic Insights Into Perinatal Outcomes of Maternal Antihypertensive Therapy During Pregnancy. | JAMA Netw Open | 2024 | 39190310 | PubTator, text mining | PubMed |
| Gastric cancer fibroblasts affect the effect of immunotherapy and patient prognosis by inducing micro-vascular production. | Front Immunol | 2024 | 39040110 | PubTator, text mining | PubMed |
| Raynaud's Phenomenon: A Current Update on Pathogenesis, Diagnostic Workup, and Treatment. | Vasc Specialist Int | 2024 | 39040029 | PubTator, text mining | PubMed |
| Integrative analysis of bulk and single-cell RNA sequencing reveals the gene expression profile and the critical signaling pathways of type II CPAM. | Cell Biosci | 2024 | 39026356 | PubTator, text mining | PubMed |
| The effect of endothelin a receptor inhibition and biological sex on cutaneous microvascular function in non-Hispanic Black and White young adults. | Physiol Rep | 2024 | 39016164 | PubTator, text mining | PubMed |
| Structural Mass Spectrometry Captures Residue-Resolved Comprehensive Conformational Rearrangements of a G Protein-Coupled Receptor. | J Am Chem Soc | 2024 | 39001877 | PubTator, text mining | PubMed |
| Editorial: Antibody-mediated rejection. | Front Transplant | 2024 | 38993768 | PubTator, text mining | PubMed |
| Functional autoantibodies against G protein-coupled receptors in hepatic and pulmonary hypertensions in human schistosomiasis. | Front Immunol | 2024 | 38953035 | PubTator, text mining | PubMed |
| Effects of an external static EF on the conformational transition of 5-HT1A receptor: A molecular dynamics simulation study. | Biophys Chem | 2024 | 38941873 | PubTator, text mining | PubMed |
| Cyclic Adenosine Monophosphate in Cardiac and Sympathoadrenal GLP-1 Receptor Signaling: Focus on Anti-Inflammatory Effects. | Pharmaceutics | 2024 | 38931817 | PubTator, text mining | PubMed |
| Prophylactic management of cerebral vasospasm with clazosentan in real clinical practice: a single-center retrospective cohort study. | Front Neurol | 2024 | 38903164 | PubTator, text mining | PubMed |
| Microarray analysis demonstrates up-regulation of the endothelin-1 gene with compensatory down-regulation of the ETA receptor gene in human portal vein. | Biosci Rep | 2024 | 38860875 | PubTator, text mining | PubMed |
| Engineered SPIONs functionalized with endothelin a receptor antagonist ameliorate liver fibrosis by inhibiting hepatic stellate cell activation. | Bioact Mater | 2024 | 38855059 | PubTator, text mining | PubMed |
| Utilizing genetics and proteomics to assess the role of antihypertensive drugs in human longevity and the underlying pathways: a Mendelian randomization study. | Eur Heart J Cardiovasc Pharmacother | 2024 | 38769606 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=8